Cargando…

Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome

BACKGROUND: In Cushing’s syndrome (CS), chronic glucocorticoid excess (GC) and disrupted circadian rhythm lead to insulin resistance (IR), diabetes mellitus, dyslipidaemia and cardiovascular comorbidities. As undifferentiated, self-renewing progenitors of adipocytes, mesenchymal stem cells (MSCs) ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Vincenzo, Mariangela, Martino, Marianna, Lariccia, Vincenzo, Giancola, Giulia, Licini, Caterina, Di Benedetto, Giovanni, Arnaldi, Giorgio, Orciani, Monia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907420/
https://www.ncbi.nlm.nih.gov/pubmed/35282448
http://dx.doi.org/10.3389/fendo.2022.816229
_version_ 1784665638135922688
author Di Vincenzo, Mariangela
Martino, Marianna
Lariccia, Vincenzo
Giancola, Giulia
Licini, Caterina
Di Benedetto, Giovanni
Arnaldi, Giorgio
Orciani, Monia
author_facet Di Vincenzo, Mariangela
Martino, Marianna
Lariccia, Vincenzo
Giancola, Giulia
Licini, Caterina
Di Benedetto, Giovanni
Arnaldi, Giorgio
Orciani, Monia
author_sort Di Vincenzo, Mariangela
collection PubMed
description BACKGROUND: In Cushing’s syndrome (CS), chronic glucocorticoid excess (GC) and disrupted circadian rhythm lead to insulin resistance (IR), diabetes mellitus, dyslipidaemia and cardiovascular comorbidities. As undifferentiated, self-renewing progenitors of adipocytes, mesenchymal stem cells (MSCs) may display the detrimental effects of excess GC, thus revealing a promising model to study the molecular mechanisms underlying the metabolic complications of CS. METHODS: MSCs isolated from the abdominal skin of healthy subjects were treated thrice daily with GCs according to two different regimens: lower, circadian-decreasing (Lower, Decreasing Exposure, LDE) versus persistently higher doses (Higher, Constant Exposure, HCE), aimed at mimicking either the physiological condition or CS, respectively. Subsequently, MSCs were stimulated with insulin and glucose thrice daily, resembling food uptake and both glucose uptake/GLUT-4 translocation and the expression of LIPE, ATGL, IL-6 and TNF-α genes were analyzed at predefined timepoints over three days. RESULTS: LDE to GCs did not impair glucose uptake by MSCs, whereas HCE significantly decreased glucose uptake by MSCs only when prolonged. Persistent signs of IR occurred after 30 hours of HCE to GCs. Compared to LDE, MSCs experiencing HCE to GCs showed a downregulation of lipolysis-related genes in the acute period, followed by overexpression once IR was established. CONCLUSIONS: Preserving circadian GC rhythmicity is crucial to prevent the occurrence of metabolic alterations. Similar to mature adipocytes, MSCs suffer from IR and impaired lipolysis due to chronic GC excess: MSCs could represent a reliable model to track the mechanisms involved in GC-induced IR throughout cellular differentiation.
format Online
Article
Text
id pubmed-8907420
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89074202022-03-11 Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome Di Vincenzo, Mariangela Martino, Marianna Lariccia, Vincenzo Giancola, Giulia Licini, Caterina Di Benedetto, Giovanni Arnaldi, Giorgio Orciani, Monia Front Endocrinol (Lausanne) Endocrinology BACKGROUND: In Cushing’s syndrome (CS), chronic glucocorticoid excess (GC) and disrupted circadian rhythm lead to insulin resistance (IR), diabetes mellitus, dyslipidaemia and cardiovascular comorbidities. As undifferentiated, self-renewing progenitors of adipocytes, mesenchymal stem cells (MSCs) may display the detrimental effects of excess GC, thus revealing a promising model to study the molecular mechanisms underlying the metabolic complications of CS. METHODS: MSCs isolated from the abdominal skin of healthy subjects were treated thrice daily with GCs according to two different regimens: lower, circadian-decreasing (Lower, Decreasing Exposure, LDE) versus persistently higher doses (Higher, Constant Exposure, HCE), aimed at mimicking either the physiological condition or CS, respectively. Subsequently, MSCs were stimulated with insulin and glucose thrice daily, resembling food uptake and both glucose uptake/GLUT-4 translocation and the expression of LIPE, ATGL, IL-6 and TNF-α genes were analyzed at predefined timepoints over three days. RESULTS: LDE to GCs did not impair glucose uptake by MSCs, whereas HCE significantly decreased glucose uptake by MSCs only when prolonged. Persistent signs of IR occurred after 30 hours of HCE to GCs. Compared to LDE, MSCs experiencing HCE to GCs showed a downregulation of lipolysis-related genes in the acute period, followed by overexpression once IR was established. CONCLUSIONS: Preserving circadian GC rhythmicity is crucial to prevent the occurrence of metabolic alterations. Similar to mature adipocytes, MSCs suffer from IR and impaired lipolysis due to chronic GC excess: MSCs could represent a reliable model to track the mechanisms involved in GC-induced IR throughout cellular differentiation. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907420/ /pubmed/35282448 http://dx.doi.org/10.3389/fendo.2022.816229 Text en Copyright © 2022 Di Vincenzo, Martino, Lariccia, Giancola, Licini, Di Benedetto, Arnaldi and Orciani https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Di Vincenzo, Mariangela
Martino, Marianna
Lariccia, Vincenzo
Giancola, Giulia
Licini, Caterina
Di Benedetto, Giovanni
Arnaldi, Giorgio
Orciani, Monia
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title_full Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title_fullStr Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title_full_unstemmed Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title_short Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome
title_sort mesenchymal stem cells exposed to persistently high glucocorticoid levels develop insulin-resistance and altered lipolysis: a promising in vitro model to study cushing’s syndrome
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907420/
https://www.ncbi.nlm.nih.gov/pubmed/35282448
http://dx.doi.org/10.3389/fendo.2022.816229
work_keys_str_mv AT divincenzomariangela mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT martinomarianna mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT laricciavincenzo mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT giancolagiulia mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT licinicaterina mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT dibenedettogiovanni mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT arnaldigiorgio mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome
AT orcianimonia mesenchymalstemcellsexposedtopersistentlyhighglucocorticoidlevelsdevelopinsulinresistanceandalteredlipolysisapromisinginvitromodeltostudycushingssyndrome